3087 Characteristics and treatment patterns of ALK+ NSCLC patients who receive second-generation ALK inhibitors: A chart review study. (September 2015) - Cadranel, J.; Park, K.; Pless, M.; Bendaly, E.; Patel, D.; Sasane, M.; Swallow, E.; Galebach, P.; Stein, K.; Marinsek, N.; Zhang, J.